Animal research has shown that common topical drugs used to treat eczema and athlete’s foot can encourage regrowth of myelin coating in damaged nerves, which may slow or stop disease progression in multiple sclerosis patients. Clinical trials have yet to begin, but research on human cells in vitro has been promising, and researchers at Case Western Reserve University are looking into ways to specifically target the nervous system with these drugs through chemical modification.


BBC News
See article in Nature here